Estrov Z - Search Results

1

A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia.

Short NJ, Borthakur G, Pemmaraju N, Dinardo CD, Kadia TM, Jabbour E, Konopleva M, Macaron W, Ning J, Ma J, Pierce S, Alvarado Y, Sasaki K, Takahashi K, Estrov Z, Masarova L, Issa GC, Montalban-Bravo G, Andreeff M, Burger JA, Miller D, Alexander L, Naing A, Garcia-Manero G, Ravandi F, Daver N. Short NJ, et al. Among authors: estrov z. Leuk Lymphoma. 2022 Sep;63(9):2161-2170. doi: 10.1080/10428194.2022.2062345. Epub 2022 Apr 20. Leuk Lymphoma. 2022. PMID: 35442137 Clinical Trial.

2

The modulatory hematopoietic activities of leukemia inhibitory factor.

Estrov Z, Talpaz M, Wetzler M, Kurzrock R. Estrov Z, et al. Leuk Lymphoma. 1992 Sep;8(1-2):1-7. doi: 10.3109/10428199209049811. Leuk Lymphoma. 1992. PMID: 1493463 Review.

3

Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.

Estrov Z, Estey EH, Andreeff M, Talpaz M, Kurzrock R, Reading CL, Deisseroth AB, Gutterman JU. Estrov Z, et al. Exp Hematol. 1992 Jun;20(5):558-64. Exp Hematol. 1992. PMID: 1587302

4

Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.

Drach D, Estrov Z, Zhao S, Drach J, Cork A, Collins D, Kantarjian H, Andreeff M. Drach D, et al. Among authors: estrov z. Leuk Lymphoma. 1994 Dec;16(1-2):79-88. doi: 10.3109/10428199409114143. Leuk Lymphoma. 1994. PMID: 7535143

5

Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.

Ferrajoli A, Talpaz M, Zipf TF, Hirsch-Ginsberg C, Estey E, Wolpe SD, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Leukemia. 1994 May;8(5):798-805. Leukemia. 1994. PMID: 8182937

6

Immature and differentiated neoplastic populations in acute lymphoid leukemia of childhood: biological and clinical implications.

Estrov Z, Re GG, Zipf TF. Estrov Z, et al. Leuk Lymphoma. 1993 Sep;11(1-2):1-7. doi: 10.3109/10428199309054724. Leuk Lymphoma. 1993. PMID: 8220141 Review.

7

Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia.

Estrov Z, Kurzrock R, Talpaz M. Estrov Z, et al. Leuk Lymphoma. 1993 Aug;10(6):407-18. doi: 10.3109/10428199309148197. Leuk Lymphoma. 1993. PMID: 8401177 Review.

8

The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences.

Roberts WM, Estrov Z, Kitchingman GR, Zipf TF. Roberts WM, et al. Among authors: estrov z. Leuk Lymphoma. 1996 Jan;20(3-4):181-97. doi: 10.3109/10428199609051607. Leuk Lymphoma. 1996. PMID: 8624456 Review.

9

Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.

Sarris AH, Talpaz M, Deisseroth AB, Estrov Z. Sarris AH, et al. Among authors: estrov z. Leukemia. 1996 May;10(5):757-65. Leukemia. 1996. PMID: 8656668

10

Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.

Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M. Lisovsky M, et al. Among authors: estrov z. Blood. 1996 Nov 15;88(10):3987-97. Blood. 1996. PMID: 8916965 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

506 results

Search Page